PPT-Status of the WHO measles and rubella laboratory manual

Accelerating progress towards measles and rubella elimination Geneva Switzerland 2123 June 2016 Jenny Rota WHO consultant Goal is to update information to reflect current responsibilities of the network provide best practices resources and guidelines. Jim Goodson, Paul Rota, David Featherstone. 11. th. Annual Measles & Rubella Initiative Meeting. Washington D.C.. September 19, 2012. Quick Quiz…. What's causing these fever and rash cases? . HHV-6 . Tenth Annual  Measles Initiative Meeting . September 13-14, 2011 Washington, DC. Sergei Deshevoi. WHO European Region . 2. Presentation outline. Regional goal and strategy. Progress towards goal. Challenges in reaching the goal in 2015. --Who We Are--. Stephen Cochi, . MD, MPH. Global . Immunization Division. Centers . for . Disease Control & Prevention. What is the Measles & Rubella Initiative? . Anne Ray Charitable Trust. Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . Measles and Rubella Laboratory network in the South East Asia. Sirima Pattamadilok. IVD WHO SEARO. The 14. th. Global Measles and Rubella Laboratory Network Meeting. Geneva, 21 June 2016. Regional Measles and Rubella Goals. Dr. Kimberly M. Thompson. Kid Risk, Inc., www.kidrisk.org. Topics. Context. I. ntegrated dynamic disease and economic . modeling. Discussion. http://www.wpro.who.int/vietnam/topics/immunization/measles_rubella/measles_rubella_big.png?ua=1. . Mona Aryal. HOD, Health Service Department. Nepal Red Cross Society. National Headquarter. . Nepal Red Cross Society’s Initiative. Vision: . to . provide immediate relief to human suffering and reduce vulnerability, under the Fundamental Principles of the Red Cross, . Dr. Khin Devi Aung. Gavi Secretariat. 21. . June 2016, Geneva. 1. #. vaccineswork. AGENDA. About Gavi, the Vaccine Alliance. Gavi’s. support to countries. Gavi’s. 2016-2020 Strategy. Gavi’s. Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . Hotel Royal, Geneva, Switzerland, 21-23 June 2016. Paul Rota,. Measles, Mumps, Rubella, Herpesviruses Laboratory Branch, CDC . par1@cdc.gov. . National Center for Immunization & Respiratory Diseases. MEA R) VACCINE What is the measles, mump and rubella (MMR) vaccine? The MMR vaccine protects against three diseases: measles, mumps and rubella (german measles). The vaccine is approved by He alth C Accelerating Progress Towards Measles and Rubella Elimination. 23 June 2016. Geneva. , Switzerland. Minal K. Patel WHO HQ IVB/EPI. Background. Growing demand for periodic cross-sectional surveys to identify population immunity gaps.  .  . Frequently Asked Questions. For Use of Teachers. Government of India has decided to introduce. measles-rubella (MR). vaccine. . The vaccine will be launched through a campaign,. to be followed by inclusion of the MR vaccine. Source. : ISIS, MESS and country reports. | . *Data as of 1 May 2023.. N=. 18,897. 20,064. 18,971. 13,009. 13,308. 41,663. 91,950. 25,693. 9,318. 14,927. Text. In the last 10 years, there was a downward trend in the notification rate of suspected measles and rubella cases, reaching its lowest point in 2021: .